Prevalence of Metabolic Syndrome in Atahualpa

Overview

A recent epidemiologic survey demonstrated a high prevalence of type 2 diabetes mellitus in Atahualpa residents. Now, the investigators attempt to evaluate the prevalence of the metabolic syndrome in adults aged 40 years or more living in this rural village of coastal Ecuador.

Full Title of Study: “Evaluation of the Prevalence of Metabolic Syndrome in Atahualpa Residents Aged 40 Years or More.”

Study Type

• Study Type: Observational [Patient Registry]
• Study Design
  • Time Perspective: Cross-Sectional
• Study Primary Completion Date: March 2013

Detailed Description

Several studies have shown that the occurrence of the metabolic syndrome is a risk factor for the development of cerebrovascular and ischemic heart disease. To evaluate the prevalence of the metabolic syndrome, we will invite all Atahualpa residents aged 40 years or more to participate in this study. For the purposes of this study we will obtain the waist circumference of all individuals, will measure their blood pressure using a standard protocol, and will take a blood sample to determine fasting glucose levels, HDL cholesterol levels, triglyceride levels, and plasma insulin levels.

Interventions

• Other: obtention of a blood sample
  • a blood sample will be obtained to measure glucose, HDL cholesterol, triglycerides, and for genetic testing

Arms, Groups and Cohorts

• obtention of a blood sample
  • all Atahualpa residents aged 40 years or more

Clinical Trial Outcome Measures

Primary Measures

• Prevalence of metabolic syndrome
  • Time Frame: 5 months
  • determination of the metabolic syndrome in subjects aged 40 years or more

Secondary Measures

• Genetic testing
  • Time Frame: 5 months
  • Blood will be taken to evaluate the ADN pattern of this population, to compare with other Amerindian populations with a proven high prevalence of diabetes mellitus and metabolic syndrome

Participating in This Clinical Trial

Inclusion Criteria

• Atahualpa resident aged 40 years or more

Exclusion Criteria

• non-consenting persons

Gender Eligibility: All

Minimum Age: 40 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

• Lead Sponsor
  • Hospital Clínica Kennedy
• Provider of Information About this Clinical Study
  • Principal Investigator: Oscar H. Del Brutto, MD, Rsearch Proffesor, Universidad de Especialidades Espiritu Santo – Hospital Clínica Kennedy
• Overall Official(s)
  • Oscar H Del Brutto, MD, Principal Investigator, Universidad de Especialidades Espiritu Santo